Glassman Wealth Services Novo Cure LTD Transaction History

Glassman Wealth Services

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$40.29 - $82.51 $322 - $660	-8 Reduced 25.0%	24 $0
Q1 2023 May 04, 2023	BUY	$56.44 - $118.81 $282 - $594	5 Added 18.52%	32 $1,000
Q3 2022 Nov 09, 2022	SELL	$67.99 - $89.57 $135 - $179	-2 Reduced 6.9%	27 $2,000
Q2 2022 Aug 04, 2022	BUY	$56.6 - $89.9 $1,641 - $2,607	29 New	29 $2,000
Q2 2020 Aug 06, 2020	SELL	$57.2 - $74.41 $457 - $595	-8 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$57.05 - $95.75 $228 - $383	4 Added 100.0%	8 $1,000
Q2 2019 Aug 08, 2019	BUY	$42.22 - $63.23 $168 - $252	4 New	4 $0

265

76.7M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.48B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.